Csenge Advisory Group’s AngioDynamics ANGO Stock Holding History

Csenge Advisory Group’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-8	Closed	–	–	264
2018 Q3	$0	Buy	+8	New	+$178	﹤0.01%	1033

Other funds holding ANGO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

Csenge Advisory Group's ANGO Position: Q4 2018 in Review

Csenge Advisory Group sold out of AngioDynamics (ANGO) in Q4 2018, closing a stake of 8 shares.

Csenge Advisory Group first reported a position in ANGO in Q3 2018 and held it in 1 quarter. The position peaked at $0 in Q3 2018. 174 funds tracked by Wall St. Rank hold ANGO as of Q4 2018.

Csenge Advisory Group reported no remaining AngioDynamics position as of Q4 2018 after selling out during the quarter.
Csenge Advisory Group sold 8 AngioDynamics shares in Q4 2018.
Csenge Advisory Group first reported a position in AngioDynamics in Q3 2018 and held it in 1 quarter.
Csenge Advisory Group's AngioDynamics position peaked at $0 in Q3 2018.
174 funds tracked by Wall St. Rank held AngioDynamics as of Q4 2018.

Based on Csenge Advisory Group's 13F filing for Q4 2018, filed 7 Feb 2019.